Researchers have investigated the relationship between Amyloid-β, the NF-κB pathway and C3 production using human control samples with post-mortem AD brains and found higher NF-κB and C3 following exposure to Amyloid-β (Lian et al. 2015). This evidence concerns the gene NFKB1 and Alzheimer disease.